| A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD) (NCT05256134) | Hoffmann-La Roche | 2022-04-19 |
| Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU) (NCT05269394) | Washington University School of Medicine | 2021-12-22 |
| An Observational Study of Aducanumab-avwa in Participants With Alzheimer's Disease in the US (NCT05097131) | Biogen | 2021-11-18 |
| Brainshuttle AD: A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Participants With Prodromal or Mild to Moderate Alzheimer's Disease (NCT04639050) | Hoffmann-La Roche | 2021-03-15 |
| Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia: A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (NCT06424236) | Washington University School of Medicine | 2020-06-03 |
| A Single Ascending Dose Study to Investigate the Safety, Tolerability, Immunogenicity and Pharmacokinetics of Intravenously Administered RO7126209 in Healthy Participants (NCT04023994) | Hoffmann-La Roche | 2019-08-03 |
| A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease (NCT03131453) | Novartis Pharmaceuticals | 2017-08-03 |
| A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease (NCT02565511) | Novartis Pharmaceuticals | 2015-11-30 |
| Markers of Alzheimers Disease and Cognitive Outcomes After Perioperative Care (NCT01993836) | Duke University | 2013-11-01 |
| Alzheimers Disease and Neuromarkers in Patients With Acute Hip Fractures (NCT02409082) | Sahlgrenska University Hospital | 2013-09-11 |
| Cognitive Behavioural Therapy for Persons With MCI or Mild Dementia (NCT02013518) | Oslo University Hospital | 2013-09-01 |
| The Feasibility of Florbetapir Quantitation (NCT01946243) | Avid Radiopharmaceuticals | 2013-08-01 |
| Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. (NCT04623242) | Washington University School of Medicine | 2012-12-01 |
| Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001 (NCT01760005) | Washington University School of Medicine | 2012-12-01 |
| A Phase 0, Open Label, Multi-center Exploratory and Safety Study of [F-18]T807 (NCT01733355) | Avid Radiopharmaceuticals | 2012-07-01 |
| A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808 (NCT01723488) | Avid Radiopharmaceuticals | 2012-07-01 |
| Non-expensive and Widely Available Tests as Diagnostic Tools in Dementia and Their Ability to Predict Disease Progression (NCT01642420) | Zealand University Hospital | 2012-04-01 |
| Identifying Potential Effects of Liraglutide on Degenerative Changes (NCT01469351) | University of Aarhus | 2012-01-01 |
| Establishment of a Bank of Biospecimens for Future Research on Age-related Cognitive Disorders (NCT00911690) | Corewell Health East | 2009-07-01 |
| Evaluation of [123I] MNI-187 and SPECT in Patients With Alzheimers Disease in Comparison to Healthy Subjects (NCT00456417) | Institute for Neurodegenerative Disorders | 2007-04-01 |
| Evaluation of [123I] AV83 and SPECT in Patients With Alzheimer Disease in Comparison to Healthy Controls (NCT00448799) | Molecular NeuroImaging | 2007-03-01 |